Xiaoshan Su
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
- Modeling and Simulation top 10%
- COVID-19 epidemiological studies
Papers in
-
- Cancer Genomics and Diagnostics 1
-
- Actinomycetales infections and treatment 1
- Co-authors
- Zhixing Zhu (9 shared papers)Weijing Wu (8 shared papers)Yiming Zeng (9 shared papers)Xihua Lian (3 shared papers)Giuseppe A. Marraro (1 shared paper)Xiaoping Lin (4 shared papers)Zenglin Wang (1 shared paper)Qiangqiang Sun (1 shared paper)
In The Last Decade
Xiaoshan Su
13 papers receiving 656 citations
Peers
Comparison fields: 5 of 110
- Infectious Diseases 271
- Modeling and Simulation 40
- Neurology 50
- Critical Care and Intensive Care Medicine 16
- Pulmonary and Respiratory Medicine 84
Countries citing papers authored by Xiaoshan Su
This map shows the geographic impact of Xiaoshan Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoshan Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoshan Su more than expected).
Fields of papers citing papers by Xiaoshan Su
This network shows the impact of papers produced by Xiaoshan Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoshan Su. The network helps show where Xiaoshan Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoshan Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 451 | |
| 2 | 2022 | 49 | |
| 3 | 2022 | 40 | |
| 4 | 2017 | 31 | |
| 5 | 2021 | 24 | |
| 6 | 2021 | 22 | |
| 7 | 2019 | 16 | |
| 8 | 2021 | 11 | |
| 9 | 2021 | 9 | |
| 10 | 2023 | 6 | |
| 11 | 2022 | 5 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 1 | |
| 14 | 2023 | 0 | |
| 15 | 2025 | 0 |
About Xiaoshan Su
Xiaoshan Su is a scholar working on Cancer Research, Microbiology, Immunology, Critical Care and Intensive Care Medicine and Molecular Biology, having authored 15 papers that have together received 668 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (1 paper), Cell Adhesion Molecules Research (1 paper), Cancer Genomics and Diagnostics (1 paper), Cancer Cells and Metastasis (1 paper), Electrocatalysts for Energy Conversion (1 paper), Advanced battery technologies research (1 paper), Actinomycetales infections and treatment (1 paper) and Supercapacitor Materials and Fabrication (1 paper). The work is most often cited by research in Infectious Diseases (271 citations), Modeling and Simulation (40 citations), Neurology (50 citations), Critical Care and Intensive Care Medicine (16 citations) and Pulmonary and Respiratory Medicine (84 citations). Xiaoshan Su has collaborated with scholars based in China, Australia and Italy. Frequent co-authors include Zhixing Zhu, Weijing Wu, Yiming Zeng, Xihua Lian, Giuseppe A. Marraro, Xiaoping Lin, Zenglin Wang, Qiangqiang Sun, Chuan Zhao and Jingjing Bai. Their work appears in journals such as Respiratory Research, BMJ Open, BMC Pulmonary Medicine, Toxicology in Vitro and Electrochimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.